Advanced Filters
noise

a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Found 10,697 clinical trials

Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus

Comparison of corneal topography based on oct OCT principle (CASIA2) with Pentacam and Scheimpflug-based biomechanical devices (Corvis ST) in screening and diagnosing keratoconus; and evaluation of the consistency with Pentacam in measuring corneal parameters (such as curvature and thickness).

years of age All Phase N/A
M Mansi Sharma, BS

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months. The secondary objective of this study is to develop a robust solution …

40 - 89 years of age All Phase N/A
A Ai Peng, MD,PhD

Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function

Evaluation on the reliability, practicability and safety of a wearable device for measuring arteriovenous fistula function based on voice print.

18 - 75 years of age All Phase N/A
S Sam Hollingworth

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease

A multicentre study to provide evidence that the relationship between an immune marker value (anti-GBS IgG concentration) and the probability of invasive GBS (iGBS) disease in infants less than 90 days of age is sufficiently strong that a vaccine able to induce an immune response will lead to a meaningful …

years of age All Phase N/A

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

This is an open label, prospective, multicenter, non-comparative study to assess the safety and effectiveness of Tabrecta® (Capmatinib) in real world setting. Also, this study is to fulfill the regulatory requirements as part of the RMP (Risk Management Plan) for Tabrecta® (Capmatinib), as requested by Korea Health Authority, MFDS (Ministry …

18 years of age All Phase N/A
R Richard Oram

Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes

Type 1 diabetes (T1D) results from destruction of insulin producing beta cells by the body's own immune system (autoimmunity) causing an individual to lose the ability to make enough insulin to control their blood sugar levels and need to have insulin injections to lower blood glucose levels. Whilst high blood …

16 - 65 years of age All Phase N/A

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.

18 years of age All Phase N/A
A Anders Näsman, MD PhD

Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.

18 years of age All Phase N/A
J Jessica Asscher

The Effectiveness of Forensic Outpatient Systemic Therapy: a Multiple Case Experimental Design

The purpose of this study is to investigate the effectiveness and mediators of Forensic Outpatient Systemic Therapy (FAST).

12 - 21 years of age All Phase N/A

Adaptive Sports for Individuals With a Physical Disability : Effect Among Stroke Survivors

The objective of the study is to evaluate the effect of engaging in adaptive sports for individuals who have had a stroke. The study is cross-sectional, participants with stroke will be recruited and divided into two groups: the first group composed of individuals with stroke who regularly participate in adaptive …

18 - 80 years of age All Phase N/A

Simplify language using AI